Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss., ...
22h
News-Medical.Net on MSNNew monoclonal antibody shows promise in treating mucormycosisMucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and those suffering from severe trauma like burns, blast injuries or victims of ...
6d
IFLScience on MSNPill That Cures Ebola In Monkeys Ignites Hopes For A Human TreatmentAs well as protecting the monkeys from death, the treatment also evoked an immune response. Senior author Dr Thomas Geisbert ...
Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.
Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...
Findings on golidocitinib for patients with non-small cell lung cancer whose disease has progressed on anti-PD-1 therapy will ...
2d
ScienceAlert on MSNAnti-Amyloid Drug May Delay Alzheimer's Symptoms in Those at Risk, Clinical Trial FindsA method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
CStone Pharmaceuticals ('CStone', HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the ...
5don MSN
Many modern drugs are based on antibodies. These proteins very specifically identify a certain structure on the surface of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results